PRODUCT SPECIFICS bioclad india in Association with

Co-presented By

BioClad is the world’s first proven antimicrobial PVC hygienic wall cladding. Antimicrobial silver ion is impregnated into the hygienic cladding panels at the time of manufacture. This helps stop the growth of bacteria and mould which works continuously for the lifetime of the panels, reducing levels of bacteria such as MRSA, E Coli, Legionella, Salmonella and mold (including Aspergillus Niger) by up to 99.99%. Please visit www.bioclad.com for more information.

1 | P a g e

Buyer Details Quotation No. Kind Attn: Co-ordinated By Delivery Location

About Reproductive Technologies Presently we are representing the following Manufacturers in South India.

1. BioClad, UK for hygienic wall cladding. 2. Adler Systems Inc, Germany for IVF Workstation, Air Handling Systems and SMS Alert Systems. 3. S Tech Associates, Mumbai

a. Memmert, Germany for range of Co2 Incubator. b. K-systems, Denmark for IVF workstations, Trigas Incubators. c. Carl Zeiss, Germany for Inverted Microscope & Stereozoom Microscope. d. S Co. Ltd., Japan for S Micromanipulator e. Microptics S.L., Spain for CASA systems f. Gynemed, Germany for IVF Culture Media & Disposables. g. Hunter Scientific, UK for ICSI & Glass Pasture Pipette

Reproductive Technologies services include IVF instrument Services and Cleanroom Technologies • PROJECT REPORT PREPARATION WITH FEASIBILITY STUDIES. • SITE SURVEY BY EXPERTS WHICH INCLUDES ARCHITECTS, CLINICIANS, & TECHNICIANS. • LAB DESIGN & EXECUTION FOR MODULAR LABS PROJECTS BY MATCHING ALL NATIONAL &

INTERNATIONAL NORMS. • CLEANROOM ENABLED CERTIFICATIONS • EQUIPMENT SELECTION & SUPPLY. • INSTALLATION & EQUIPMENT’S OPERATING TRAINING ON SITE. • SUPPLY OF DISPOSABLES & MEDIA. • QUALITY CONTROL CHECKS FOR VOC, pH, HUMIDITY, TEMPERATURE, CO2%, O2%, HYGIENE OF

SURFACE/WATER, PARTICLE COUNT OF ALL FILTERATION SYSTEM. If you need any further details then feel to contact us.

For, Reproductive Technologies

LAKSHMIKANTHAN,

SALES HEAD

Mb: +91-9380853888

Email: bioclad@reproductivetechnologies.in

2 | P a g e

Table of Contents

WHAT IS BIOCLAD? .......................................................................................................................................................... 3

WHAT DOES BIOCLAD DO? ............................................................................................................................................. 3

WHAT IS BIOCOTE® TECHNOLOGY .............................................................................................................................. 4

WHERE CAN IT BE USED? ................................................................................................................................................ 5

CASE STUDY: FIRST EVER TRIAL AT HEARTLANDS HOSPITAL ............................................................................... 6

BIOCLAD MICROBIAL TESTS .......................................................................................................................................... 8

Bioclad E-Coli MRSA Test ................................................................................................................................................. 8

Advanced BioClad Fire Certification................................................................................................................................. 9

BIOCLAD & VOC............................................................................................................................................................... 10

INSTALLATION AND FITTING ....................................................................................................................................... 11

OVERSEAS INSTALLATIONS .......................................................................................................................................... 12

INDIA INSTALLATIONS .................................................................................................................................................. 13

CALCULATING AREA REQUIRED FOR BIOCLAD ........................................................................................................ 14

SAMPLE QUOTE ............................................................................................................................................................... 15

TEAM INDIA - BIOCLAD ................................................................................................................................................. 16

CONTACT US .................................................................................................................................................................... 16

3 | P a g e

Go To Table of Contents

WHAT IS BIOCLAD?

BioClad – The World’s First Antimicrobial PVC Wall Cladding Containing BioCote® Technology BioClad antimicrobial hygienic wall cladding is a unique product, ideal for almost any environment where a hygienic surface finish is paramount. PVC wall cladding has become an increasingly popular alternative to traditional methods because it offers a range of sophisticated finishes and colours while maintaining its hygienic integrity. BioClad are continuously developing and improving our range of hygienic wall cladding products and services to provide our customers with the most comprehensive hygienic solutions and the highest standards in design and function. BioClad PVC wall cladding has silver ions embedded at the time of manufacture, which means that antimicrobial protection is active throughout every sheet and provides 24/7 protection for the lifetime of the product. BioClad antimicrobial wall cladding remains effective even when scratched because our antimicrobial protection cannot be washed away. The BioClad PVC cladding system is effective at significantly reducing the incidence of bacteria, microbes, protozoans and fungi. This has been proven in both clinical and independent field trials. BioClad panels are now widely used throughout our own National Health Service (NHS)

WHAT DOES BIOCLAD DO?

Utilising Antimicrobial Technology, BioClad will:

Inhibit growth of MRSA, E.coli, Legionella, Salmonella and Mould by up to 99.9% PROVEN Continues to control bacteria 24/7 Guaranteed protection for expected lifetime of BioClad BioClad will guarantee ADDED VALUE to your hygienic cladding package

4 | P a g e

Go To Table of Contents WHAT IS BIOCOTE® TECHNOLOGY

BioClad is the world’s first proven antimicrobial PVC hygienic wall cladding. Antimicrobial silver ion is impregnated into the hygienic cladding panels at the time of manufacture. This helps stop the growth of bacteria and mould which works continuously for the lifetime of the panels, reducing levels of bacteria such as MRSA, E Coli, Legionella, Salmonella and mould (including Aspergillus Niger) by up to 99.99%. BioClad has been proven to work in real-world environments. An independent study was undertaken in a UK care home kitchen where 35 surfaces were tested for their bacteria levels. The BioClad hygienic wall cladding registered a 0 level of bacteria. BioClad incorporates silver ion antimicrobial technology. Silver ion technology is a safe, natural antimicrobial that is added at our point of manufacture ensuring it is present throughout our virgin PVC sheets.

5 | P a g e

Go To Table of Contents WHERE CAN IT BE USED?

6 | P a g e

Go To Table of Contents

CASE STUDY: FIRST EVER TRIAL AT HEARTLANDS HOSPITAL

BioCote® – Proven reduction in

bacterial contamination in the

hospital environment

BACKGROUND The control of healthcare-associated infections (HCAIs) remains a priority for healthcare providers, who are employing a combination of infection prevention and control strategies, including hand hygiene, cleaning, training and the adoption of new technologies, to tackle the problem. As a result, a wide range of infection control products and technologies are emerging on the market, including antimicrobial technology. BioCote Ltd works with equipment manufacturers, engineering silver ion technology into a variety of healthcare related products, helping them to resist the growth of bacteria and mould on their surface. Silver is an ideal antimicrobial agent because it has a high efficacy against a wide range of medically-important microorganisms and is regarded as non-toxic. For the NHS to employ new technologies and products they need to show a demonstrable ability to contribute positively to infection control. The use of any product that claims it has antimicrobial efficacy should be supported by a robust evidence-base. AIM A pilot study, conducted at the Heart of England NHS Foundation Trust, investigated to what extent BioCote® antimicrobial products can reduce microbial contamination in a healthcare environment.

95.8% Reduction in the total hospital environment

92.6% Reduction in BioCote protected products

43.5% Reduction in adjacent

non-protected products

In laboratory tests, BioCote® antimicrobial materials regularly demonstrate reductions in counts of E. coli and S.aureus greater than 95%, compared with untreated samples. The aim of this study was to determine to what degree this high level of antimicrobial efficacy could be achieved in a real-life hospital environment.

7 | P a g e

Go To Table of Contents STUDY Two outpatient units provided the environments for this 18 month pilot study. Unit A was refurbished with BioCote®-treated products including blinds, tiles, door handles, sack holders and light switches and also a number of untreated products. A similar, refurbished outpatient ward containing untreated items (unit B), served as a control. Both outpatient units were similar in terms of volume of people, layout and floor-surface area and were subjected to standard cleaning practice. Both were allowed to function for 12 months before swabbing commenced. Swabs were collected over a five month period from BioCote®-treated and untreated products in both outpatient units. Swabs were processed for total counts of viable bacteria and results expressed as average counts of colony-forming units (CFUs). RESULTS CFU counts from BioCote®-treated products in unit A were between 62% and 98% lower than from comparable, untreated products in unit B. The products used in the trial were manufactured from a variety of materials e.g plastics and fabrics. CFU counts from these different materials were also compared. CFU counts from BioCote®-treated materials were between 70% (fabrics) to 99% (laminates) lower than untreated equivalents. CFU counts from BioCote®-treated products in unit A were compared with CFU counts from untreated products in both unit A and unit B. CFU counts on untreated products in unit A were also compared to untreated products in unit B. This three way comparison provides the following results: the average CFU count from any BioCote® treated product was 95.8% lower than that from any untreated product in unit B the average CFU count from any BioCote® treated product was 92.6% lower than that from any untreated product in the same environment (unit A) the average CFU count from any untreated product in unit A was 43.5% lower than that from any untreated product in unit B. DISCUSSION Results suggest that BioCote® antimicrobial products will demonstrate the same high level of antimicrobial efficacy in a real-life environment as seen in laboratory tests, e.g an average bacterial reduction of 95.8%. In addition to the effect of standard cleaning, BioCote® antimicrobial products showed sustained reductions in bacterial counts, compared to untreated products. Because BioCote® technology does not wear out or wipe off surfaces it can provide a continuous decontamination effect. Treated products can complement cleaning practices, helping to continually reduce levels of bacteria on surfaces and in the wider healthcare environment. Bacterial contamination on untreated products in unit A was on average 43.5% lower compared with untreated products in unit B. This suggests that a reduction in bacteria on BioCote® antimicrobial surfaces results in lower numbers of bacteria on other surfaces because there are fewer bacteria being transferred. Using a number of antimicrobial objects in a healthcare environment may therefore help the decontamination of the wider environment. CONCLUSIONS This study, first published in the Journal of Infection Prevention1, highlights the ability of BioCote®-treated antimicrobial products to reduce levels of bacteria contaminating healthcare settings.

8 | P a g e

Go To Table of Contents BIOCLAD MICROBIAL TESTS

Bioclad E-Coli MRSA Test

9 | P a g e

Go To Table of Contents

Advanced BioClad Fire Certification

10 | P a g e

Go To Table of Contents BIOCLAD & VOC

11 | P a g e

Go To Table of Contents INSTALLATION AND FITTING

12 | P a g e

Go To Table of Contents

OVERSEAS INSTALLATIONS

Healthcare - Blackpool NHS, Lancashire FY3 8NR, United Kingdom

Education - Croxteth Primary School, Merseyside L11 0BP, United Kingdom

Food - Loch Fyne - Coco Inn, Strachur PA27 8BX, United Kingdom

13 | P a g e

Go To Table of Contents

INDIA INSTALLATIONS

Ramachandra Medical College and Hospital, Porur, Chennai

NU Hospital, Rajajinagar, Bangalore Aaditya Fertility Center, Chennai

Lifeline Hospital, Adoor, Kerala Bhoomi Fertility Center, Bangalore

14 | P a g e

Go To Table of Contents CALCULATING AREA REQUIRED FOR BIOCLAD FACILITY DIMENSION

FACILITY #1

FACILITY NAME OPERATION THEATRE

FACILITY SIZE LENGTH BREADTH HEIGHT

10 15 9

JOINT TYPE WELDING

J-JOINT [BOTTOM] Yes

COVING [CEILING] Yes

Ceiling (Length x Breadth) = 10 x 15 = 150 Sq.Ft.

Wall 1 (Length x Height) = 10 x 9 = 90 Sq.Ft.

Wall 2 (Breadth x Height) = 15 x 9 = 135 Sq.Ft.

90 x 2(Wall 3, not visible in drawing) = 180 Sq.Ft

135 x 2(Wall 4, not visible in drawing) = 270 Sq.Ft

A

B

C

A + B + C => 150 + 180 + 270 => 600 Sq.Ft.

15 | P a g e

Go To Table of Contents SAMPLE QUOTE

QUOTE FOR THE SAMPLE AREA CALCULATED ABOVE

QUOTATION @ STANDARD RATE FOR LOWEST SQUARE FEET

BUYER DETAILS QTN NO: RT-BC-XXX-15-16 {CUSTOMER NAME} DATE: {DATE} {HOSPITAL NAME} CO-ORDINATED BY {ADDRESS IN FULL} {REPRESENTATIVE NAME} {CITY, STATE} LOCATION {CONTACT NO} {INSTALLATION LOCATION}

Dear Sir/Madam, With reference to the above drawing, herewith attaching you the best offer for bioclad procurement and installation. Please go through the same and get in touch for any clarifications.

S.No Facility

Code Description of Work

Facility Dimension (Feet)

Work Area (in Sq. Feet)

Units Rate

(INR) Cost Price

(INR)

1 BC01

BioClad Wall & Ceiling Panel Antimicrobial PVC Sheets Special Cladding Paste Welded Joints with Antimicrobial Rods Cladding on Walls and Ceiling

10 x 15 x 9 600 - 800.00 4,80,000.00

2 BC01 BioClad Antimicrobial Doors 4 Feet 1 80,000.00 80,000.00 Total Before Tax 5,60,000.00

Terms & Conditions Taxes VAT & Service Tax extra as applicable for material with labor Total Duration 8 Weeks From the date of confirmed order along with payment receipt Payment Terms Advance (PO) 80% Balance (On Delivery) 20% Installation Details Location {INSTALLATION LOCATION} Duration of Installation 15 Days Installation By Reproductive Technologies Material Dispatch Mode Surface Quote Validity 15 Days Ordering Details Ordering Address Reproductive Technologies India Private Limited #10, 2nd Floor, Balamuthu Street, Ellis Road, Mount Road, Chennai, Tamilnadu: 600002, India Bank Details Bank Name: Axis Bank Ltd. Branch: Kilpauk, Chennai Account No: 915020016739863 IFSC Code: UTIB0000620

For, Reproductive Technologies Authorized Signatory ____________________________________

16 | P a g e

Go To Table of Contents TEAM INDIA - BIOCLAD

CONTACT US

https://www.facebook.com/Biocladsindia

Skype Name: biocladindia

Call us @ +91 93808 53888 +91 93807 52888 +91 94426 38379